/PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial launch of a new.
BD FACSDuet™ Premium System Leverages Robotics to Automate Sample Preparation for Greater Standardization in Clinical Flow Cytometry Diagnostics
FRANKLIN LAKES, N.J., June 12, 2023. | June 13, 2023